Navigation Links
Human embryonic stem cells purified in new, rapid technique
Date:8/6/2010

UCSF researchers are reporting the first success in very rapidly purifying one type of embryonic stem cell from a mix of many different types of embryonic stem cells in the culture dish. The technique, which avoids the need to genetically alter the cells to distinguish them, is a key advance, the researchers say, for obtaining the appropriate cells for repairing specific damaged tissues.

The new strategy links two existing technologies for the first time: the ability to identify specific embryonic stem cell types in a culture of different embryonic stem cells, and a way to efficiently sort them at a very high rate, a procedure known as "high throughput" processing.

"Before stem cell therapy can become routine, clinicians will need a plentiful and certain supply of pure stem cells that is capable of forming the particular tissue to be repaired, and is free of contamination by other cell types. But the goal of rapidly and safely harvesting vast numbers of a single stem cell type without altering the cell's genome has been challenging," says Harold Bernstein, MD PhD, UCSF professor of pediatrics, a member of the UCSF Cardiovascular Research Institute and senior author of the paper.

"Here we were able to purify one specific cell type without resorting to genetically engineering the stem cells themselves, a process that can introduce unwanted traits into the cells."

The research finding is currently published online in the journal Stem Cells and Development, and will appear later this year in a print edition of the journal. Embryonic stem cells, which replicate indefinitely in the culture dish, are capable of forming almost any tissue in the body. Over time, they begin to specialize as specific cell types, such as cardiomyocytes of the heart or neurons of the brain. One goal for stem cell therapy is to be able to identify cells that have begun to specialize in a particular way so that they could serve as a source of cell
'/>"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Scientists develop the first model for investigating the origins of testicular cancer in humans
2. Scientists unravel human-ecosystem interactions
3. UCLA scientists for the first time identify a cell-of-origin for human prostate cancer
4. Plant compound resveratrol shown to suppresses inflammation, free radicals in humans
5. Non-human sugar in biotech drugs causes inflammation
6. Cancer-metabolism link runs deep in humans
7. UCLA scientists isolate the first stages of tissue production in human embryonic stem cells
8. New way to conquer disease-causing nematodes in flies has implications for human diseases
9. Another Reason to Buy a Hot Tub: Bullfrog Donates Spa to Humanitarian Effort
10. NOSCAR announces first NOTES transoral and transvaginal gallbladder removals performed as part of US multicenter human trial
11. World Renowned Humanitarian and Spiritual Leader Sri Sri Ravi Shankar Brings Timely Message of Peace and Empowerment to Connecticut
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 Imagine No Malaria’s 2014 World Malaria ... Innovator Award , an honor given to nonprofit causes that ... Nonprofit Technology Conference (NTC15) in Austin, Texas. The ... Church in Austin, was on hand for the presentation; she ... Malaria. , Imagine No Malaria was one of five finalists ...
(Date:3/4/2015)... Orlando, Florida (PRWEB) March 04, 2015 ... includes a 6.2 mile swim, 261.4 mile bike, and ... with a total time of 24:45:45. , "This race ... thankful to my wonderful team and sponsors for supporting ... , Ultraman Florida 2015 had a total of 40 ...
(Date:3/4/2015)... New York (PRWEB) March 04, 2015 ... ) that allege the statin drug caused patients to ... the U.S. District Court, District of South Carolina. According ... be convened on March 26, 2015 at 10:00 a.m. ... directed to submit a Joint Status report to the ...
(Date:3/4/2015)... 04, 2015 Cook For Your Life ... teaches healthy cooking to people touched by cancer, is ... The program, run by founder Ann Ogden, will be ... Management. The unique partnership will expand the program from ... CFYL in 2007. After going through her own cancer ...
(Date:3/4/2015)... With the growing influence of movies, television, video games and ... adults, combined with the increasingly frantic lifestyle of modern parents, ... up with what kids are into these days. It seems ... daily basis. , The same is also true for drugs ... to discreetly talk about them, are constantly changing. These tips ...
Breaking Medicine News(10 mins):Health News:Imagine No Malaria Receives Care2 Innovator Award 2Health News:Imagine No Malaria Receives Care2 Innovator Award 3Health News:Living Fuel Champion Christian Isakson Finishes Second In UltraMan Florida Test of Endurance 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:Drexel University and Cook for Your Life Team Up 2Health News:Drexel University and Cook for Your Life Team Up 3Health News:Drexel University and Cook for Your Life Team Up 4Health News:Drexel University and Cook for Your Life Team Up 5Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2
... Closed-Chest, Bypass Surgery; Created Robotic Bypass ... Reproducibility of Procedure and Decrease Learning Curve ... Cardica, Inc.,(Nasdaq: CRDC ) today ... is innovating robot-assisted,minimally-invasive cardiac bypass surgery with ...
... 28 CYNACON / OCuSOFT(R),(OCuSOFT(R), Inc.), a ... to ophthalmologists and optometrists, is pleased to,announce ... OCuSOFT(R) Lid Scrub(TM),Plus is now available in ... *(Photo Caption: OCuSOFT(R) Lid Scrub(TM) PLUS), ...
... access to insurance tend to have healthier children , , WEDNESDAY, ... care in America varies widely from state to state, ... likelihood of living long and healthy lives. , That,s the ... a private foundation that seeks to promote better health care ...
... /PRNewswire-FirstCall/ - Innolife Pharma, Inc.,(Other OTC:INNP.PK - ( ... that,they have unveiled their new website. This new ... more comfortable feeling with regards to what,INNP is ... About Innolife Pharma Inc., --------------------------, Innolife ...
... Glycoproducts International,Inc., a provider of nutritional ... jury sitting in the Northern District of ... that Glycoproducts International, Inc.,committed patent infringement of ... to Mannatech,s AMBROTOSE(R) technology., The jury ...
... Histologies Achieved, Improvement in Overall Survival when ... The type of non-small,cell lung cancer (NSCLC) patients have ... outcome according to the results of a major,study published ... study was announced by Eli Lilly and Company., ...
Cached Medicine News:Health News:Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardica's C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons 2Health News:Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardica's C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons 3Health News:Renowned Leader and Educator in Robotic Cardiac Bypass Surgery Leverages Cardica's C-Port(R) Flex-A(R) Anastomosis System in His Practice and to Educate Cardiothoracic Surgeons 4Health News:CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies 2Health News:States' Scorecard Finds Big Differences in Kids' Health Care 2Health News:States' Scorecard Finds Big Differences in Kids' Health Care 3Health News:Jury Rules in Favor of Glycoproducts International, Inc. 2Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 2Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 3Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 4Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 5Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 6Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 7Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 8Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 9Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 10Health News:Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer 11
(Date:3/4/2015)... GSI Group Inc. (NASDAQ: GSIG ... and supplier of precision photonics and motion control components ... technology markets, today reported financial results for the fourth ... financial results in this press release are GAAP measures ... fourth quarter of 2014, GSI generated revenue of $94.0 ...
(Date:3/4/2015)... Calif. , March 4, 2015  Nevro Corp. ... that has developed and commercialized an innovative, evidence-based neuromodulation ... that it will release financial results for the fourth ... on Wednesday, March 18, 2015. Company management will host ... (4:30 p.m. Eastern Time) on Wednesday, March 18, 2015. ...
(Date:3/4/2015)... The March 3, 2015, order from the Federal Drug Administration ... labels to clarify the drugs, intended use and warn about ... to protect the public from injury from these products, according ... Hanly Conroy . The order says that the ... currently taken by millions of U.S. men – are approved ...
Breaking Medicine Technology:GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 10GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 11GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 12GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 13GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 14GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 15GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 16GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 17GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 18GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 19GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 20GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 21GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 23GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 24GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 25GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 26GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 27GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 28GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 29GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 30GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 31GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 32GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 33Simmons Hanly Conroy, LLC: FDA Orders Label Warnings on Testosterone Drugs Concerning Normal Aging Use and Heart Attack-Stroke Risks 2
... , PALO ALTO, Calif., Dec. 2 Varian, Inc. (Nasdaq: ... with the U.S. Securities and Exchange Commission its Annual Report on ... This Annual Report may be accessed through the Company,s web site ... on "10-K" in the table shown. Stockholders may receive a ...
... , NEW YORK, Dec. 2 ... is available in its catalogue: , Pharmaceutical ... http://www.reportlinker.com/p0164248/Pharmaceutical-Contract-Manufacturing---Global-Market-Trends.html , Global pharma ... competition in generic markets, rising cost of new product ...
Cached Medicine Technology:Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5
Jography angiographic catheter has a new material combination, a patented angled weld, a flat wire braid design with a XXL lumen. It also has an atraumatic soft tip....
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: